Abstract. Parthenolide is a natural product from the shoots of Tanacetum parthenium that has been demonstrated to have immunomodulatory effects in a number of diseases. The present study aimed to determine the effect and mechanism of parthenolide on the apoptotic ability of H 2 O 2 -induced osteoblasts. Cell viability was analyzed with a MTT assay and the apoptotic rate was subsequently measured using flow cytometry. The activity of the antioxidative enzymes superoxide dismutase (SOD) and glutathione peroxidase (GPX), and the serum marker enzymes alkaline phosphatase (ALP), malondialdehyde (MDA) and lactate dehydrogenase (LDH) was measured. Reverse transcription-quantitative polymerase chain reaction and western blot analyses were performed to analyze the expression levels of osteogenesis and oxidative stress-associated genes. The results indicated that parthenolide increased cell viability and inhibited the apoptosis of H 2 O 2 -induced osteoblasts. Parthenolide decreased the levels of reactive oxygen species, MDA, LDH and ALP. SOD and GPX levels were increased by parthenolide in H 2 O 2 -induced osteoblasts. This suggested that parthenolide may break the equilibrium state of oxidative stress and inhibit cellular apoptosis. Parthenolide additionally increased the expression levels of oxidative stress-associated genes, including nuclear factor erythroid 2 like 2, hemeoxygenase-1 and quinone oxidoreductase 1 in H 2 O 2 -induced osteoblasts. Furthermore, parthenolide increased the expression of osteogenesis-associated genes, including runt-related transcription factor 2, osteopontin, osteocalcin and collagen 1 in H 2 O 2 -inducedosteoblasts. Therefore, it was concluded that parthenolide may be used in the treatment of osteoporosis.
Introduction
Osteoporosis is among the most common health problems in the elderly (1) . Normal calcium homeostasis and supplementation are associated with good bone health (2) . However, it has been demonstrated that calcium supplementation may cause a variety of adverse conditions, including cardiovascular disease, constipation and kidney stone development (3, 4) . Therefore, the discovery of novel osteoporosis therapies is of high importance.
Cellular apoptosis may be induced by a number of factors (5, 6) . Among the most important factors is oxidative stress (7) . Oxidative stress has been confirmed to be associated with osteonecrosis (8, 9) . Hydrogen peroxide (H 2 O 2 ) is a strong oxidizer which is able to induce cells to produce large amounts of reactive oxygen species (ROS) (10) . ROS are produced in mitochondria as normal products of cellular metabolism. Elevated ROS is related to oxidative stress, causing cellular dysfunction and apoptosis (11, 12) . ROS may damage double-stranded DNA, leading to abnormal variation (13, 14) and may additionally induce oxidative stress-induced apoptosis in tissues (15, 16) . H 2 O 2 is a key metabolite of oxidation reactions and, therefore, has critical involvement in the pathology of diseases mediated by oxidative stress (15, 16) . Accumulating evidence has indicated that H 2 O 2 may regulate cell function and induce cell death (17) . H 2 O 2 may additionally penetrate the cell membrane and act as a secondary messenger in signal transduction pathways (18) . A previous study indicated that the manner of H 2 O 2 -induced cell death is associated with cell type, H 2 O 2 concentration and the type of stimulation received (19) .
Parthenolide is a traditional medicine with immunomodulatory effects (20) . It has additionally been demonstrated to have the potential to treat certain types of cancer, including leukemia, and hepatic and breast cancer (21) (22) (23) (24) . Parthenolide is able to regulate multiple cellular and molecular signals in order to induce tumor cell apoptosis (25) . It may additionally regulate the expression of the apoptosis regulator Bcl-2 (Bcl-2) protein family and caspases (25) , and promote the loss of mitochondrial function (26) . This evidence highlights the potential use of parthenolide in tumor therapy.
The specific effects of parthenolide on osteoblasts are not completely understood. Therefore, the purpose of the present study was to investigate the effect of parthenolide on osteoblast proliferation and apoptosis. First, the effects of parthenolide on osteoblast viability and H 2 O 2 -induced apoptosis were demonstrated. The influence of parthenolide on the expression of ROS, malondialdehyde (MDA), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), superoxide dismutase (SOD) and glutathione peroxidase (GPX) in H 2 O 2 -inducedosteoblastswas additionally investigated. The regulation of oxidative stress-associated and osteogenesis-associated gene expression by parthenolide was subsequently analyzed. The results of the present study indicated that parthenolide may be used as a therapy for osteoporosis.
Materials and methods
Osteoblast sample. Osteoblasts were acquired from an 8-year-oldpatient with developmental dislocation of the hip. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assay. Total RNA was obtained using TRIzol (Thermo Fisher Scientific, Inc.), and RNA was reverse-transcribed to cDNA using a Revert Aid First Strand cDNA Synthesis kit (Thermo Fisher Scientific, Inc.) with random primers, according to the manufacturer's protocol. SYBR-Green PCR Master Mix kit (Takara Biotechnology Co., Ltd., Dalian, China) was used to detect the mRNA expression levels, and the assay was performed on an ABI 7500 system (Thermo Fisher Scientific, Inc.). Thermocycling conditions were: 95˚C for 15 sec; 40 cycles at 95˚C for 10 sec, 59˚C for 10 sec and 72˚C for 15 sec. The relative mRNA expression levels were normalized to GAPDH. The data were analyzed using the 2 -ΔΔCt method (27) . The primer sequences were as follows: Bcl-2 forward, 5'-GCC TTC TTT GAG TTC GGT GG-3' and reverse, 5'-GAA ATC AAA CAG AGG CCG CA-3'; apoptosis regulator BAX (Bax) forward, 5'-GAG CTG CAG AGG ATG ATT GC-3' and reverse, 5'-CCA ATG TCC AGC CCA TGA TG-3'; runt related transcription factor 2 (Runx2) forward, Western blot analysis. Total protein was extracted using radioimmunoprecipitation assay buffer (Beyotime Institute of Biotechnology, Shanghai, China) with a protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific, Inc., Waltham, MA, USA). The concentration was measured using the Pierce Bicinchoninic Acid Protein Assay kit (Thermo Fisher Scientific, Inc.) and detected using a protein reagent (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Proteins (30 µg) were separated on a 10% SDS-PAGE gel and transferred to polyvinylidene difluoride membranes (PerkinElmer Inc., Waltham, MA, USA). The membranes were blocked with 5% low-fat milk (BD Biosciences, Franklin Lakes, NJ, USA) for 2 h at room temperature and subsequently incubated with the following primary antibodies overnight at 4˚C: Anti-GAPDH (1:2,000; cat. no. ab8245; Abcam, Cambridge, UK), anti-Bax (1:1,000; cat. no. ab32503; Abcam), anti-Bcl-2 (1:1,000; cat. no. ab32124; Abcam), anti-Runx2 (1:1,500; cat. no. ab23981; Abcam), anti-OPN (1:1,500; cat. no. ab166709; Abcam), anti-OCN (1:1,500; cat. no. ab93876; Abcam), anti-Col-1 (1:1,000; cat. no. ab6308; Abcam), anti-Nrf2 (1:1,000; cat. no. ab62352; Abcam), anti-HO1 (1:1,200; cat. no. ab69544; Abcam) and anti-NQO1 (1:1,000; cat. no. ab28947; Abcam). The membranes were incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (1:1,000; cat. no. ab97165; Abcam) for 2 h at room temperature. The protein expression levels were detected using the enhanced chemiluminescence substrate kit (Thermo Fisher Scientific, Inc.) and the enhanced chemiluminescence detection system (GE Healthcare, Chicago, IL, USA). The densitometric analysis was performed by Labworks Software (version 4.5; UVP, Inc., Upland CA, USA).
ROS, SOD, MDA, GPX and LDH activity detection.
Osteoblasts were treated with PBS, 0.8 mmol/l H 2 O 2 or 0.8 mmol/l H 2 O 2 and parthenolide (5, 10 and20 µM) for 12, 24 and 48 h. The fluorescent dye dihydroethidium (DHE; cat. 309800; Merck KGaA, Darmstadt, Germany) was used to measure ROS activity, as described previously (28) . Treated cells were incubate d with 2.5 mmol/l DHE for 25 min at 37˚C. Cells were subsequently washed with PBS, digested with 0.25% trypsin (Sigma-Aldrich; Merck KGaA) and incubated with DHE. The results were detected by using flow cytometry equipped with an argon laser and Cell Quest™ software (version 3.3; BD Biosciences, Franklin Lakes, NJ, USA). The experiment was repeated at least three times. SOD and MDA activity was detected using a commercial kit (Sigma-Aldrich; Merck KGaA) (29) and a MDA activity assay kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China), respectively, according to the manufacturers' protocols. LDH activity was detected using a diagnostic kit (cat. no. GL2623; Randox Laboratories Ltd., Crumlin, UK), according to the method of Cabaud and Wroblewski (30) . GPX enzyme activity was detected using the cellular GPX assay kit (Sigma-Aldrich; Merck KGaA) as described previously (31) . The colorimetric reactions of LDH and GPX were determined using a microplate spectrophotometer system (BioRad-680, Bio-Rad Laboratories, Inc.) at 440 and 412 nm, respectively.
ELISA analysis. Osteoblasts were treated with PBS (control), 0.8 mmol/l H 2 O 2 or 0.8 mmol/l H 2 O 2 and parthenolide (5, 10 and 20 µM) for 12, 24 and 48 h. Treated osteoblasts were subsequently washed with PBS and centrifuged at 1,000 x g for 5 min at 4˚C. The culture supernatant (500 µl) was harvested and ALP activity was measured using an ELISA kit (cat. AR001, R&D Systems, Minneapolis, MN, USA), according to the manufacturer's protocol. A 96-well plate was incubated with anti-ALP (1:1,000, cat. no. ab83259; Abcam) for 1 h at 37˚Cand subsequently incubated with HRP-conjugated secondary antibody (1:5,000; cat. no. ab97165; Abcam) for 1 h at 37˚C. The absorbance was measured at 450 nm using a Multiskan GO microplate spectrophotometer (Thermo Fisher Scientific, Inc.).
Cell viability assay. Treated osteoblasts (2x10
3 cells/well) were seeded into a 96-well plate and maintained at 37˚C for 12, 24 and 48 h. At the indicated time-points (12, 24 and 48 h), 15 µl MTT solution (5 mg/ml) was added into each well, respectively. Following incubation for 4 h, cells were treated with 150 µl dimethylsulfoxide. The absorbance was measured using a microplate reader at 490 nm. Statistical analysis. Results were analyzed using SPSS 13.0 (SPSS, Inc., Chicago, IL, USA), and the statistical significance was calculated using Student's paired t-test and one-way and/or multiple-comparison analysis of variance followed by Tukey's test. All data are presented as the mean ± standard deviation of three repeated experiments. P<0.05 was considered to indicate a statistically significant difference.
Results
Effect of parthenolide on osteoblast viability. Under the microscope, control osteoblasts were observed to be triangular, polygonal or irregular. The nuclei were elliptical with one or two nucleoli and black cytoplasmic particles were present. The dark nuclei in the cells were positive for ALP ( Fig. 2C-E) .
Effect of parthenolide on

Parthenolide decreases the levels of ROS, MDA, LDH and ALP, and increases SOD and GPX levels in H 2 O 2 -inducedosteoblasts.
Cellular apoptosis and proliferation are two important events affected by oxidative stress (32) (33) (34) (35) . Numerous studies have demonstrated that ROS levels are closely associated with the induction of apoptosis in a number of pathophysiological conditions (36, 37) . Oxidative stress may cause an imbalance between ROS and activity of antioxidative enzymes, including SOD and GPX (38) . The influence of parthenolide and H 2 O 2 on serum marker enzymes MDA, LDH and ALP was additionally investigated (39) . Osteoblasts were treated with PBS, 0.8 mmol/l H 2 O 2 or 0.8 mmol/l H 2 O 2 and parthenolide (5, 10 and 20 µM) for 24 h. The results indicated that H 2 O 2 significantly increased ROS (Fig. 3A) , MDA (Fig. 3C), LDH (Fig. 3D) and ALP (Fig. 3F ) levels. SOD (Fig. 3B) (Runx2, OPN, OCN, Fig. 5 ).
Parthenolide upregulates osteogenesis-associated genes
Discussion
Large-scale and multi-directional osteoporosis research has made significant progress worldwide. The study of the effect of Chinese medicine in the process of bone collagen formation remains in its infancy, particularly in regards to the underlying molecular mechanisms (41) . Tanacetum vulgare is an herbage used as a traditional Chinese medicine for its analgesic, antibacterial and anti-tumor properties; it is used to treat fever, migraine and joint pain (42) . Tanacetum vulgare contains a variety of medicinal ingredients, including parthenolide, which is an active component of the sesquiterpene lactones (43) . Recent studies have demonstrated that parthenolide has strong anti-tumor activity and may enhance the sensitivity of tumor cells to apoptosis signaling (44) . The molecular mechanism of action of parthenolide in osteoporosis is unclear.
Oxidative stress is an inevitable condition in all organisms. A series of adaptive mechanisms exist to protect cells from damage, although various harmful stimuli may cause an imbalance in the equilibrium of oxidation, leading to the induction of apoptosis and even pathological damage (45) . Oxidative stress may induce apoptosis through the mitochondrial, death receptor and endoplasmic reticulum stress pathways (46) , in addition to through the activation of the protein kinase, nuclear factor-κB and caspase pathways (47) . It has been demonstrated that oxidative stress may be a risk factor associated with the development and progression of osteoporosis (48) . Increasing evidence additionally suggests that ROS accumulation leads to oxidative stress under conditions of aging and certain illnesses or medicines, contributing to the development and progression of osteoporosis (49) .
The present study demonstrated that parthenolide inhibited the decrease in osteoblast viability and the increase in apoptosis mediated by H 2 O 2 . Parthenolide additionally decreased Bax expression and increased Bcl-2 expression in osteoblasts induced by H 2 O 2 . The expression of osteogenesis-associated genes Runx2, OPN, OCN and Col-1 was increased in H 2 O 2 -induced osteoblasts. Additionally, previous studies (38, 50) revealed that oxidative stress affects the activity of the antioxidant enzymes SOD and GPX and serum marker enzymes MDA, LDH and ALP (38, 50) . The present study demonstrated that parthenolide decreased the H 2 O 2 -induced increase in ROS, MDA, LDH, and ALP levels. SOD and GPX levels were also rescued in H 2 O 2 -induced osteoblasts.
A previous study indicated that parthenolide, a sesquiterpene lactone obtained from Tanacetum pathenium, has high antineoplastic activity (44) . Parthenolide has been demonstrated to inhibit the growth and induce the death in vitro of numerous tumor cell types, including liver cancer, cholangiocarcinoma and multiple myeloma (44, (51) (52) (53) . Furthermore, parthenolide has been demonstrated to enhance the sensitivity of cancer cells to therapy, including liver cancer cell sensitivity to cisplatin (54, 55 Nrf2 is a transcription factor that regulates the intracellular metabolism of endogenous and exogenous substances in the oxidative stress response. Nrf2 binds to the antioxidant response element (1) and up-regulates ARE-associated antioxidative genes, including endogenous antioxidants, phase II detoxification enzymes and transcripts encoding intracellular genes that determine cell survival or death (56) . The sustained expression of Nrf2 has important functions in restoring cellular homeostasis (57) . A number of natural or synthetic small molecule compounds have been confirmed to activate the Nrf2/ARE signaling pathway, resulting in protection of cells from toxic or carcinogenic material-induced cell damage (58) . Nrf2/ARE pathway activation results in the expression of cytoprotective enzymes, including NQO1 and HO-1 (58). Therefore, Nrf2 has an essential role in protection against oxidative stress. The results of the present study indicated that parthenolide increased Nrf2, HO-1 and NQO1 expression in H 2 O 2 -induced osteoblasts. Therefore, parthenolide may suppress osteoblast apoptosis by reducing oxidative stress.
In conclusion, the results of the present study confirmed that parthenolide increased viability and inhibited apoptosis in H 2 O 2 -induced osteoblasts. The decrease in apoptosis mediated by parthenolide may be via a reduction in oxidative stress. 
